Discover
CVS
CVS Health Corporation
104.81
400 x undefined
100 x undefined
bid
ask
+
1.36
1.31%
undefined @ 04:00 PM
104.81 +0.00 (0.00%)
| Ytd | 32.07% | |
| 1y | 50.63% |
102.77
day range
104.87
58.50
52 week range
106.15
| Open | 103.41 | Prev Close | 103.45 | Low | 102.77 | High | 104.87 | Mkt Cap | 133.73B |
| Vol | 7.43M | Avg Vol | 8.34M | EPS | 2.28 | P/E | 45.97 | Forward P/E | 12.50 |
| Beta | 0.62 | Short Ratio | 2.87 | Inst. Own | 90.28% | Dividend | 2.66 | Div Yield | 2.57 |
| Ex Div Date | 04-23 | Earning | 07-30 | 50-d Avg | 92.87 | 200-d Avg | 81.42 | 1yr Est | 105.69 |
| Income Statement | |||
| Total Revenue | 100.43B | ||
| Revenues (USD) | 100.43B | ||
| Cost of Revenue | 84.80B | ||
| Gross Profit | 15.62B | ||
| Operating Expenses | 10.94B | ||
| Selling, General and Administrative Expense | 10.94B | ||
| Operating Income | 4.68B | ||
| Interest Expense | 774.00M | ||
| Income Tax Expense | 981.00M | ||
| Net Income | 2.94B | ||
| Net Income Common Stock | 2.94B | ||
| Net Income Common Stock (USD) | 2.94B | ||
| Consolidated Income | 2.96B | ||
| Net Income to Non-Controlling Interests | 14.00M | ||
| Earnings per Basic Share | 2.31 | ||
| Earnings per Basic Share (USD) | 2.31 | ||
| Earnings per Diluted Share | 2.30 | ||
| Dividends per Basic Common Share | 0.67 | ||
| Earning Before Interest & Taxes (EBIT) | 4.70B | ||
| Earning Before Interest & Taxes (USD) | 4.70B | ||
| Weighted Average Shares | 1.27B | ||
| Weighted Average Shares Diluted | 1.28B | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.54B | ||
| Cash and Equivalents (USD) | 9.54B | ||
| Investments | 34.67B | ||
| Investments Current | 2.26B | ||
| Investments Non-Current | 32.41B | ||
| Trade and Non-Trade Receivables | 40.99B | ||
| Current Assets | 74.82B | ||
| Property, Plant & Equipment Net | 27.78B | ||
| Total Assets | 252.97B | ||
| Debt Current | 4.48B | ||
| Total Debt | 78.35B | ||
| Current Liabilities | 86.41B | ||
| Debt Non-Current | 73.86B | ||
| Total Liabilities | 175.34B | ||
| Accumulated Retained Earnings (Deficit) | 63.28B | ||
| Accumulated Other Comprehensive Income | 201.00M | ||
| Shareholders Equity | 77.46B | ||
| Shareholders Equity (USD) | 77.46B | ||
| Assets Non-Current | 178.16B | ||
| Total Debt (USD) | 78.35B | ||
| Goodwill and Intangible Assets | 110.55B | ||
| Inventory | 17.77B | ||
| Liabilities Non-Current | 88.93B | ||
| Trade and Non-Trade Payables | 16.92B | ||
| Tax Liabilities | 3.77B | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -2.32B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.06B | ||
| Capital Expenditure | -849.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.00M | ||
| Issuance (Purchase) of Equity Shares | 103.00M | ||
| Issuance (Repayment) of Debt Securities | -1.52B | ||
| Payment of Dividends & Other Cash Distributions | -847.00M | ||
| Net Cash Flow from Investing | -874.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -27.00M | ||
| Net Cash Flow from Operations | 4.25B | ||